Original Publication Date: 1 December, 2014
Publication / Source: International Journal of Hematologic Oncology
Authors: Christopher J Ott
There has been tremendous progress in the treatment of acute lymphoblastic leukemia (ALL) with modern chemotherapeutic regimens, especially in pediatric cases. However, patients with T-cell acute lymphoblastic leukemia (T-ALL) have a higher risk for early relapse than those with other ALL subtypes, and these cases have a substantially poorer overall prognosis .